prostate header graphic
Prostate Problem Guide

Prostate Cancer Treatments For Early And Advanced Prostate Cancer

There is a wide range of prostate cancer treatments available today and the treatment that your doctor recommends will depend to a very large extent upon the progression of the disease. Thereafter it is a matter of discussing each treatment option with your doctor and of considering the advantages and disadvantages of each, as well as of course looking carefully at the risks which all prostate cancer treatments carry.

Prostrate cancer treatments fall into two broad categories – those that are recommended for early (Stage I and Stage II) cancer which is confined to the prostate gland and those used to treat advanced (Stage III and Stage IV) cancer which has spread to other areas of the body.

Early stage cancer treatments are designed to remove the prostate or to destroy it and thus to stop the cancer cells before they have a chance to spread to other areas of the body.

The surgical removal of the prostate gland (prostatectomy) will normally be carried out as either traditional open surgery or using a less invasive laparoscopic approach. One recent development is the introduction of robotic surgery (using the da Vinci system) which has the advantage of preserving nerves, muscles and other structures in the area of the prostate. Robotic surgery is extremely effective but should be carried out by a highly skilled surgeon in a centre with considerable experience in using this technique.

Radiation therapy may also be used to kill the cancer cells within the prostate gland. A variety of different radiation therapy techniques may be used and treatment will normally be carried out over a period of several weeks.

A relatively new technique, which is still being evaluated, is known as cryosurgery. During cryosurgery, which is carried out under anesthesia, cooling probes are guided into the prostate using ultrasound and the cancer cells are killed by freezing them.

Terms from the prostate cancer glossary:

ANTIBODY: protein produced by the immune system as a defense against an invading or 'foreign' material or substance (an antigen);for example, when you get a cold, your body produces antibodies to the cold virus.

FINASTERIDE: an inhibitor of the enzyme (5 alpha-reductase or 5AR) that stimulates the conversion of testosterone to DHT; used to treat BPH and prostate cancer.

OSTEOPOROSIS: a reduction in bone density resulting in a T score of -2.5 or less; a loss of bone due to increased osteoclastic activity leading to bone resorption.

TRANSITION: change; for example, the transition zone of the prostate is the area of the prostate closest to the urethra and has features that distinguish it from the much larger peripheral zone.

The final form of treatment used for early stage cancer is high intensity focused ultrasound (HIFU). This procedure is again carried out under anesthesia (or using a local spinal anesthetic) and a probe is placed into the prostate gland through the rectum. A beam of high intensity focused ultrasound is them used to raise the temperature in the area of focus and thus to kill the cancer cells.

For late stage prostate cancer hormone therapy is used and this is designed not to attack the cancer itself but to target the male hormones (in particular testosterone) which the cancer cells need to grow.

Late stage treatments will include orchiectomy (the removal of the testicles), which is designed to remove the source of the body’s main production of testosterone, or a variety of hormone treatments aimed at either reducing the level of testosterone and other male hormones in the body or of blocking their action.

In cases where hormone therapy proves ineffective, systematic radiation therapy or chemotherapy may be recommended.

Whatever the stage of your cancer it is important to consider all of the options carefully and weigh the advantages, disadvantages and risks of each carefully before choosing the treatment that is best for you.

Further information on prostate cancer treatment:

Cancer Can Be Beat - Discover Moose Jaw


CTV.ca

Cancer Can Be Beat
Discover Moose Jaw
That optimism was apparent on the weekend as federal NDP Leader Jack Layton revealed he has been diagnosed with prostate cancer. "There's a lot of different ...
Layton gives few details on cancer fightCBC.ca
NDP Leader Admits Bout With Prostate CancerAHN | All Headline News
Thank you, Jack LaytonCJBK (blog)
Cornwall Free News (blog) -Toronto Sun -Sault Star
all 343 news articles »

Making Good Decisions About Cancer: One Survivor's Tale - Huffington Post (blog)


UrbanMecca

Making Good Decisions About Cancer: One Survivor's Tale
Huffington Post (blog)
When Neville was told he had prostate cancer at age 54, he thought he knew exactly what the costs and benefits were: Unless he got treatment, ...
New Advances in Prostate Cancer Screening Prostate Saturation BiopsiesPR Web (press release)
PROSTATE CANCER SLOWEDPeterborough Examiner

all 6 news articles »

Amgen: denosumab prostate cancer goal meets goals - Reuters


Amgen: denosumab prostate cancer goal meets goals
Reuters
Amgen said overall adverse events, including infections, were generally similar between the two treatment groups. Osteonecrosis of the jaw, ...
Denosumab Demonstrated Superiority Over Zometa(R) in Pivotal Phase 3 Head-to ...PR Newswire (press release)
Amgen: Third Clinical Trial Shows Denosumab Beats ZometaWall Street Journal
Market Report -- In Play (AMGN)MSN Money
RTT News
all 23 news articles »

Lower detection of prostate cancer with PSA screening in US than in a European ... - EurekAlert (press release)


Lower detection of prostate cancer with PSA screening in US than in a European ...
EurekAlert (press release)
The natural progression of prostate cancer and the sensitivity (percentage of men correctly identified as having prostate cancer of those who have ...
Beyond the Abstract - Detection rate and factors predictive the presence of ...UroToday

all 4 news articles »